TipRanks
Arrowhead Pharmaceuticals (MX:ARWR)
:ARWR
Mexico Market
ARWR
Arrowhead Pharmaceuticals
RESEARCH TOOLSreports

Arrowhead Pharmaceuticals (ARWR) Stock News & Sentiment

0 Followers
Arrowhead: Early ARO-DIMER-PA Data Validate DIMER Platform and Support Buy Rating on Emerging Multi-Target RNAi Potential
Premium
Ratings
Arrowhead: Early ARO-DIMER-PA Data Validate DIMER Platform and Support Buy Rating on Emerging Multi-Target RNAi Potential
3d ago
ARWR
Arrowhead Pharmaceuticals Earnings Call Signals Confident Expansion
Premium
Company Announcements
Arrowhead Pharmaceuticals Earnings Call Signals Confident Expansion
1M ago
ARWR
Arrowhead: Buy Rating Reiterated as Redemplo Momentum Builds and Pipeline Catalysts Support Unchanged $120 Price Target
Premium
Ratings
Arrowhead: Buy Rating Reiterated as Redemplo Momentum Builds and Pipeline Catalysts Support Unchanged $120 Price Target
2M ago
ARWR
Arrowhead: Strong Phase III Plozasiran Data and Priority Review Voucher Drive Accelerated Path to Market and $3B Global Sales Outlook, Supporting Buy Rating
Premium
Ratings
Arrowhead: Strong Phase III Plozasiran Data and Priority Review Voucher Drive Accelerated Path to Market and $3B Global Sales Outlook, Supporting Buy Rating
2M ago
ARWR
Is ARWR a Buy, Before Earnings?
Premium
Pre-Earnings
Is ARWR a Buy, Before Earnings?
2M ago
ARWR
Arrowhead Pharmaceuticals (ARWR) Stock Soars on Strong Phase 3 Trial Results
Premium
Market News
Arrowhead Pharmaceuticals (ARWR) Stock Soars on Strong Phase 3 Trial Results
2M ago
ARWR
Arrowhead’s ARO-033 First-in-Human Trial: What Early Safety Progress Means for ARWR Investors
Premium
Company Announcements
Arrowhead’s ARO-033 First-in-Human Trial: What Early Safety Progress Means for ARWR Investors
2M ago
ARWR
More MX:ARWR News >

ARWR News on the Web

Arrowhead Pharmaceuticals, Inc. at Morgan Stanley Global Healthcare Conference Transcript
GuruFocus News
Neutral
Arrowhead Pharmaceuticals Director Sells 11,600 Shares for $1 Million
The Motley Fool
Bullish
Analysts Are Bullish on These Healthcare Stocks: Cytokinetics (CYTK), Ionis Pharmaceuticals (IONS)
TipRanks News
Bullish
Arrowhead Pharmaceuticals, Inc. KOL Event (Virtual) Transcript
GuruFocus News
Neutral
Analysts Conflicted on These Healthcare Names: Arrowhead Pharmaceuticals (ARWR), BioMarin Pharmaceutical (BMRN) and Ionis Pharmaceuticals (IONS)
TipRanks News
Bullish
Analysts Are Bullish on Top Healthcare Stocks: CapsoVision, Inc. (CV), Arrowhead Pharmaceuticals (ARWR)
TipRanks News
Bullish
Arrowhead Phase 3 SHASTA-3, SHASTA-4 studies met primary endpoints
TipRanks News
Bullish
Could Arrowhead Pharmaceuticals (ARWR)’s Plozasiran Become the Catalyst for a Major Stock Re-rating?
Insider Monkey
Bullish

News Score - Last 7 Days

Very Positive
MX:ARWR
Sector Average
Media Buzz
This Week4 articles
Weekly Average4.5 articles
News Sentiment
This Week100%
Sector Average91%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is MX:ARWR’s Media Buzz Sentiment?
4 articles about MX:ARWR were published this week. In an average week, 4.5 articles are published.
    What is MX:ARWR’s weekly average amount of articles?
    In an average week, 4.5 articles about MX:ARWR are published.
      What is MX:ARWR’s News Sentiment?
      100% of articles about MX:ARWR were positive this week, compared to its sector average of 91%.
        Healthcare Stocks that are Trending in the News
        ASNDAscendis Pharma
        CRBPCorbus Pharmaceuticals
        RVMDRevolution Medicines
        BNTCBenitec Biopharma
        GNNSFGenscript Biotech
        Showing the stocks with the most bullish news sentiment over the past week